GLP-1RAs could substantially reduce mortality in patients with brain metastases and Type 2 diabetes. Read more.
MedPage Today on MSN
GLP-1 Drugs May Benefit Cancer Patients With Brain Lesions
Retrospective study finds link between blockbuster drugs and longer survival ...
Weight-loss injections that have become famous for helping people shed pounds may also help some patients with advanced cancer live longer when the disease has spread to the brain, according to a new ...
Scientists have developed a genetically engineered virus that triggers the immune system to hunt and destroy glioblastoma brain tumours ...
Among patients with cancer, brain metastases, and type 2 diabetes, GLP-1 use is associated with lower all-cause mortality, ...
Scientists studying the cellular origins of pineoblastoma discovered a dependency applicable to anatomically distinct brain tumor types, which may be therapeutically targetable. During early human ...
Researchers at Wake Forest University School of Medicine developed engineered immune cells that can cross the blood-brain barrier and slow lung cancer brain metastases, offering a promising new ...
Scientists have found a way to make one of the most aggressive brain tumors vulnerable to the immune system. A single injection of a modified virus can invade glioblastoma, kill cancer cells, and ...
Similarities among three pediatric brain tumors that arise in different structures of the CNS – pineoblastoma, retinoblastoma and Group 3 medulloblastoma – have been linked to their shared origin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results